Drugs interactions for

  • 0 Major drug interactions
  • 26 Moderate drug interactions (including ingredients like Articaine, Benzocaine, Benzyl alcohol)
  • 0 Minor drug interactions
26 interactions for
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and .
Articaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Articaine.
Benzocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Benzocaine.
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Benzyl alcohol.
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Bupivacaine.
Butamben
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Butamben.
Capsaicin
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Capsaicin.
Chloroprocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Chloroprocaine.
Cinchocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Cinchocaine.
Cocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Cocaine.
Darbepoetin alfa
The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Talimogene laherparepvec.
Diphenhydramine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Diphenhydramine.
Dyclonine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Dyclonine.
Erythropoietin
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Talimogene laherparepvec.
Etrasimod
The risk or severity of immunosuppression can be increased when Talimogene laherparepvec is combined with Etrasimod.
Lidocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Lidocaine.
Meloxicam
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Meloxicam.
Mepivacaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Mepivacaine.
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Talimogene laherparepvec.
Oxybuprocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Oxybuprocaine.
Phenol
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Phenol.
Pramocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Pramocaine.
Prilocaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Prilocaine.
Procaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Procaine.
Proparacaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Proparacaine.
Ropivacaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Ropivacaine.
Tetracaine
The risk or severity of methemoglobinemia can be increased when Talimogene laherparepvec is combined with Tetracaine.